# A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy Participants

> **NCT06835465** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Divarasib
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT06835465
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-21
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-05-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835465, "A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06835465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*